TerrAscend (TSNDF) Total Non-Current Liabilities (2020 - 2026)

TerrAscend (TSNDF) reported Total Non-Current Liabilities of $390.5 million for Q1 2026, up 8.97% year-over-year from $358.3 million in Q1 2025, and up 3.18% quarter-over-quarter from $378.4 million in Q4 2025.

TerrAscend (TSNDF) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 7 years of Total Non-Current Liabilities data on file, last reported at $390.5 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $390.5 million, up 8.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $390.5 million (up 8.97% YoY), and the FY2025 annual result was $378.4 million, up 11.51% from the prior year.
  • Total Non-Current Liabilities grew to $390.5 million in Q1 2026 per TSNDF's latest filing, from $378.4 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $390.5 million in Q1 2026 and troughed at $218.8 million in Q4 2023.
  • A 5-year average of $319.3 million and a median of $339.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities plunged 32.16% in 2023, then jumped 59.75% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $242.5 million in 2022, then declined by 9.79% to $218.8 million in 2023, then soared by 55.12% to $339.4 million in 2024, then grew by 11.51% to $378.4 million in 2025, then increased by 3.18% to $390.5 million in 2026.
  • Business Quant data shows TSNDF's Total Non-Current Liabilities at $390.5 million in Q1 2026, $378.4 million in Q4 2025, and $383.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 TerrAscend - - 34.60 Mn 390.48 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 390.48 Mn
Dec 31, 2025 378.43 Mn
Sep 30, 2025 383.47 Mn
Jun 30, 2025 361.96 Mn
Mar 31, 2025 358.34 Mn
Dec 31, 2024 339.37 Mn
Sep 30, 2024 371.36 Mn
Jun 30, 2024 356.64 Mn
Mar 31, 2024 224.31 Mn
Dec 31, 2023 218.78 Mn
Sep 30, 2023 303.50 Mn
Jun 30, 2023 292.66 Mn
Mar 31, 2023 246.20 Mn
Dec 31, 2022 242.51 Mn
Sep 30, 2022 274.32 Mn
Jun 30, 2022 323.25 Mn
Mar 31, 2022 362.90 Mn
Dec 31, 2021 286.79 Mn
Dec 31, 2020 -118.94 Mn